A detailed history of Wells Fargo & Company transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Wells Fargo & Company holds 31,038 shares of CLBT stock, worth $698,975. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,038
Holding current value
$698,975
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$11.61 - $17.52 $360,351 - $543,785
31,038 New
31,038 $522,000
Q4 2023

Feb 09, 2024

BUY
$6.45 - $8.76 $10,965 - $14,892
1,700 New
1,700 $14,000

Others Institutions Holding CLBT

About Cellebrite DI Ltd.


  • Ticker CLBT
  • Exchange NASDAQ
  • Sector Technology
  • Industry Software—Infrastructure
  • Shares Outstandng 189,648,992
  • Market Cap $4.27B
  • Description
  • Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...
More about CLBT
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.